[HTML][HTML] Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer

S Cameron, G Deblois, JR Hawley, A Qamra, S Zhou… - Oncogene, 2023 - nature.com
Predicting and treating recurrence in intermediate-risk prostate cancer patients remains a
challenge despite having identified genomic instability and hypoxia [,] as risk factors. This …

Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer.

S Cameron, G Deblois, JR Hawley, A Qamra, S Zhou… - Oncogene, 2023 - europepmc.org
Predicting and treating recurrence in intermediate-risk prostate cancer patients remains a
challenge despite having identified genomic instability [1] and hypoxia [2, 3] as risk factors …

[HTML][HTML] Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer

S Cameron, G Deblois, JR Hawley, A Qamra, S Zhou… - Oncogene, 2023 - ncbi.nlm.nih.gov
Predicting and treating recurrence in intermediate-risk prostate cancer patients remains a
challenge despite having identified genomic instability [1] and hypoxia [2, 3] as risk factors …

Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer

S Cameron, G Deblois, JR Hawley, A Qamra… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Predicting and treating recurrence in intermediate-risk prostate cancer patients remains a
challenge despite having identified genomic instability [1] and hypoxia [2, 3] as risk factors …

Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer.

S Cameron, G Deblois, JR Hawley, A Qamra, S Zhou… - Oncogene, 2023 - europepmc.org
Predicting and treating recurrence in intermediate-risk prostate cancer patients remains a
challenge despite having identified genomic instability [1] and hypoxia [2, 3] as risk factors …